Principal Financial Group
KROS icon

Principal Financial Group’s Keros Therapeutics KROS Stock Holding History

Principal Financial Group’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$658K Buy
+59,594
New +$920K ﹤0.01% 2002
2024
Q3 		– Sell
-5,265
Closed -$241K – 2321
2024
Q2 		$241K Sell
5,265
-1,798
-25% -$96.6K ﹤0.01% 2105
2024
Q1 		$468K Buy
7,063
+574
+9% +$34K ﹤0.01% 1997
2023
Q4 		$258K Sell
6,489
-23
-0.4% -$721 ﹤0.01% 2102
2023
Q3 		$208K Sell
6,512
-100
-2% -$3.73K ﹤0.01% 2158
2023
Q2 		$266K Buy
6,612
+735
+13% +$32.2K ﹤0.01% 2106
2023
Q1 		$251K Sell
5,877
-400
-6% -$20.2K ﹤0.01% 2128
2022
Q4 		$301K Buy
+6,277
New +$293K ﹤0.01% 2095
2021
Q1 		– Sell
-3,140
Closed -$221K – 2490
2020
Q4 		$221K Buy
+3,140
New +$198K ﹤0.01% 2293

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return